Pharmacokinetics of linezolid and ertapenem in experimental parapneumonic pleural effusion

Journal of Inflammation

Volumn 7, Issue , 2010, Pages

  Saroglou, Maria ^a   Tryfon, Stavros ^a   Ismailos, Georgios ^b   Liapakis, Ioannis ^c   Tzatzarakis, Manolis ^d   Tsatsakis, Aristidis ^d   Papalois, Apostolos ^b   Bouros, Demosthenes ^c  

^a G PAPANICOLAOU HOSPITAL   (Greece)

^b ELPEN Research Experimental Centre   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ERTAPENEM; LINEZOLID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG PENETRATION; EMPYEMA; ESCHERICHIA COLI; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; RABBIT; THORACOCENTESIS;

ESCHERICHIA COLI; ORYCTOLAGUS CUNICULUS;

EID: 77953831106     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-7-22     Document Type: Article

References (41)

1. Parapneumonic Pleural Effusions and Empyema. D Bouros, Pleural Disease New York, Marcel Dekker, Bouros D, 2004
2. Consensus guidelines on the management of community-acquired pneumonia in adults. LA Mandell RG Wunderink A Anzueto JG Bartlett GD Campbell NC Dean SF Dowell TM File Jr DM Musher MS Niederman A Torres CG Whitney Infectious Diseases Society of America; Infectious Diseases Society of America/American Thoracic Society, Clin Infect Dis 2007 44 Suppl 2 27 72 10.1086/511159 17278083
3. Parapneumonic effusions and empyema. SA Sasse, Curr Opin Pulm Med 1996 2 520 526
4. Management of parapneumonic pleural effusions and empyema. C Strange SA Sahn, Infect Dis Clin North Am 1991 5 539 559 1955699
5. Parapneumonic effusion and empyema: best therapeutic approach. D Bouros M Plataki KM Antoniou, Monaldi Arch Chest Dis 2001 56 144 8 11499304
6. The effects of early chest tube placement on empyema resolution. S Sasse T Nguyen M Mulligan W Nai-San K Mahutte RW Light, Chest 1997 111 1679 1683 10.1378/chest.111.6.1679 9187193
7. Pharmacokinetics and pharmacodynamics in the pleural space. IE Liapakis I Kottakis RW Light D Bouros, Pleural Diseases New York, Marcel Dekker, Bouros D, 2004 999 1008
8. Parapneumonic effusion and empyema. H Hamm RW Light, Eur Respir J 1997 10 1150 1156 10.1183/09031936.97.10051150 9163661
9. Utility of fibrinolytic agents for draining intrapleural infections. D Bouros S Schiza N Siafakas, Semin Respir Infect 1999 14 39 47 10197396
10. Turpentine pleurisy in rabbits: a model of pleural fluid acidosis and low pleural fluid glucose. SA Sahn DE Potts, Am Rev Respir Dis 1978 118 893 901 32820
11. Comparison of the use and accuracy of methods for determining pleural fluid pH. TM Chandler EH McCoskey RP Byrd Jr TM Roy, South Med J 1999 92 214 217 10.1097/00007611-199902000-00010 10071670
12. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. M Marel B Stastny L Melinova E Svandova R Light, Chest 1995 107 1598 1603 10.1378/chest.107.6.1598 7781353
13. Determination of linezolid in plasma by reversed-phase high performance liquid chromatography. GW Peng RP Stryd S Murata M Igarashi K Chiba H Aoyama M Aoyama T Zenki N Oza, Journal of Pharm Biomed Anal 1999 20 1-2 65 73 10.1016/S0731-7085(98)00310-0 (Pubitemid 29206584)
14. Assay of ertapenem in human serum by high performance liquid chromatography. M Soltani A MacGowan A Lovering, Int J Antimicrobial Agents 27 2006 165 167
15. A simple, isocratic high performance liquid chromatography assay for linezolid in human serum. CM Tobin J Sunderland LO White AP MacGowa, Journal of Antimicrobial Chemotherapy 2001 48 605 608 10.1093/jac/48.5.605 11679548
16. Antibiotic levels in empyemic pleural fluid. LR Teixeira SA Sasse MA Villarino T Nguyen ME Mulligan RW Light, Chest 2000 117 1734 1739 10.1378/chest.117.6.1734 10858410
17. Penetration of clarithromycin in experimental pleural empyema model fluid. IE Liapakis RW Light MS Pitiakoudis AJ Karayiannakis Giamarellos- Bourboulis G Ismailos S Anagnostoulis CE Simopoulos DE Bouros, Respiration 2005 72 296 300 10.1159/000085371 15942299
18. Penetration of newer quinolones in the empyema fluid. IE Liapakis I Kottakis MN Tzatzarakis AM Tsatsakis MS Pitiakoudis P Ypsilantis RW Light CE Simopoulos DE Bouros, Eur Respir J 2004 24 466 470 10.1183/09031936.04.00007804 15358708
19. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. D Shinabarger K Marotti R Murray A Lin E Melchior S Swaney D Dunyak W Demyan J Buysse, Antimicrob Agents Chemother 1997 41 2132 2136 9333037
20. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. S Swaney H Aoki M Ganoza D Shinabarger, Antimicrob Agents Chemother 1998 42 3251 3255 9835522
21. Linezolid in prophylaxis against experimental aortic valve endocartitis with enterococcus faecalis. G Athanassopoulos A Pefanis V Sakka D Liopoulos D Perrea H Giamarellou, Antimicrob Agents Chemother 2006 50 2 654 7 10.1128/AAC.50.2.654-657.2006 16436723
22. Efficacy of linezolid in a staphylococcal endocarditis rabbit model. MP Oramas-Shirey LV Buchanan CL Dileto-Fang CF Dailey CW Ford DH Batts JK Gibson, J of Antimicr Chemother 2001 47 349 352 10.1093/jac/47.3.349
23. Continuation of a randomized, double-blind, multicenter study of linezolid in patients with nosocomial pneumonia. RG Wunderink SK Cammarata TH Oliphant MH Kollef, Clin Ther 2003 25 3 980 92 10.1016/S0149-2918(03)80118-2 12852712
24. Linesolid versus ceftriaxone/cefpodoxime in patients hospitalized for the pneumonia. GS San Pedro SK Cammarat TH Oliphant T Todisco, Scand J Infect Dis 2002 34 10 720 8 10.1080/0036554021000026933 12477321
25. Linezolid vs vancomysin: analysis of two double-blind studies of patients with aureus nosocomial pneumonia. RG Wunderink J Rello SK Cammarata RV Croos-Dabrera MH Kollef, Chest 2003 124 5 1789 97 10.1378/chest.124.5.1789 14605050
26. Intrapulmonary pharmacokinetics of linezolid. JE Conte JA Golden Jr J Kipps E Zurlinden, Antimicrob Agents Chemother 2002 46 5 1475 1480 10.1128/AAC.46.5.1475-1480.2002 11959585
27. Successful treatment with linezolid of meningitis complicated with subdural empyema in a 6-month-old boy. EC Dinleyici C Yarar M Dinleyici A Yakut, J of Trop Pediatrics 2007 53 6 431 433 10.1093/tropej/fmm058
28. Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative staphylococcus ventriculitis. LM Boak J Li D Spelman P du Cros RL Nation CR Rayner, The Annals of Pharmacotherapy 2006 40 7-8 1451 1455 16772405
29. Properties and potential of ertapenem. DM Livermore AM Sefton, J Antimicrob Chemother 2003 52 331 44 10.1093/jac/dkg375 12917243
30. Pharmacokinetics of ertapenem in healthy young volunteers. AK Majumbar DG Musson KL Birk CJ Kitchen S Holland J McCrea G Mistry M Hesney L Xi SX Li R Haesen RA Blum RL Lins H Greenberg S Waldman P Deutsch JD Rogers, Antimicrob Agents Chemother 2002 46 3506 11 10.1128/AAC.46.11.3506-3511.2002 12384357
31. Comparative in vitro activities of carbapenem L-749,345 and other antimicrobials against multiresistant gram-negative clinical pathogens. G Jacoby P Han J Tran, Antimicrob Agents Chemother 1997 41 1830 1 9257772
32. Intra-abdominal sepsis: newer interventional and antimicrobial therapies. JS Solomkin J Mazuski, Infect Dis Clin North Am 2009 23 3 593 608 10.1016/j.idc.2009.04.007 19665085
33. Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: A prospective, multicenter, randomized, double-blind study. S Roy I Higareda E Angel-Muller M Ismail C Hague B Adeyi GL Woods H Teppler, Infect Dis Obstet Gynecol 2003 11 1 27 37 10.1155/ S1064744903000048 12839630
34. A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults. G Ortiz-Ruiz J Caballero-Lopez IR Friedland GL Woods A Carides Protocol 018 Ertapenem Community-Acquired Pneumonia Study Group, Clin infect Dis 2002 34 1076 1083 10.1086/339543 11914996
35. Activities of ertapenem, a New Long-Acting Carbapenem, against Penicillin-Sensitive or-Resistant Pneumococci in Experimental Menigitis. P Cottagnoud M Pfister M Cottagnoud F Acosta MG Tauber, Antimicrobial Agents and Chemotherapy 2003 47 6 1943 1947 10.1128/AAC.47.6.1943-1947.2003 12760871
36. Pharmacokinetic study of pleural fluid penetration of carbapenem antibiotic agents in chemical pleurisy. T Niwa A Nakamura T Kato T Kutsuna K Katou H Morita Y Kojima M Itoh, Respir Med 2006 100 2 324 31 10.1016/j.rmed.2005.05.009 16493791
37. Pharmacokinetic study of penetration of meropenem into pleural effusion in patients with pleurisy. J Makino M Kanke E Nakashima M Kamata S Ozawa H Maruyama K Masuhara T Kobayashi, Jpn J Antibiot 2002 55 1 77 88 11977923
38. Antibiotics and mucous membrane: pharmacokinetic aspects. F Fraschini R Nebuloni R Cortelazzi M Falchi, J Chemother 1991 3 suppl 1 182 9 12041761
39. Effect of protein binding on penetration of-lactams into rabbit peripheral lymph. G Wooddnutt V Berry L Mizen, Antimicrob Agents Chemother 1995 39 2678 83 8593001
40. Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection. T Sakuma H Kubo T Tanita K Koike S Fujimura, Thorac Cardiovasc Surg 1994 107 955 957
41. In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus. C Jacqueline J Caillon O Grossi V Le Mabecque AF Miegeville D Bugnon E Batard G Potel, Antimicrob Agents Chemother 2006 50 7 2547 9 10.1128/AAC.01501-05 16801442